Natural Biocon (India) Ltd Fair Value
NATURAL · Commodities · Current price ₹3.55
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹10 | 0% ROE fading to 13% over ~3 yrs, on ₹12 book |
| Relative P/E | ₹9 | EPS × 67.5 peer-median P/E |
| Graham floor | ₹6 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is Natural Biocon (India) Ltd undervalued?
DocStoX estimates the fair value of Natural Biocon (India) Ltd at ₹9 per share, versus the current market price of ₹4. That puts the stock about +148.7% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is medium.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹10), Relative P/E (₹9), Graham floor (₹6). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹6 (bear) to ₹9 (base) to ₹10 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on Natural Biocon (India) Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.